Related Experiment Video
Updated: Jan 6, 2026
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
Generation of TD50 values for carcinogenicity study data
Andrew Thresher1, John Paul Gosling2, Richard Williams1
1Lhasa Limited , Granary Wharf House , 2 Canal Wharf , Leeds , West Yorkshire LS11 5PS , UK .
This study presents a transparent method for calculating carcinogenic potency (TD50) values, crucial for chemical risk assessment and human safety thresholds. The new method, applied to existing data, shows high correlation but highlights discrepancies due to the outdated Carcinogenic Potency Data Base (CPDB) methodology.
Area of Science:
- Toxicology
- Chemical Risk Assessment
- Carcinogenesis
Background:
- Carcinogenic potency is vital for chemical risk assessment, informing metrics like threshold of toxicological concern (TTC), acceptable intake (AI), and permitted daily exposure (PDE).
- The Carcinogenic Potency Data Base (CPDB) historically provided TD50 values but is no longer updated, necessitating a re-evaluation of its methodology.
- Accurate carcinogenic potency data is essential for establishing safety thresholds and minimizing human exposure to potential carcinogens.
Purpose of the Study:
- To develop a transparent and consistent methodology for calculating TD50 values from dose-response data.
- To re-calculate TD50 values using the new methodology on data previously used by the CPDB.
- To analyze the correlation between the newly calculated TD50 values and those from the CPDB, identifying sources of discrepancies.
Main Methods:
- Development of a transparent methodology for TD50 calculation from experimental dose-response data.
- Application of the developed methodology to the dataset utilized by the Carcinogenic Potency Data Base (CPDB).
- Comparative analysis and correlation assessment between the TD50 values generated by the new methodology and the original CPDB values.
Main Results:
- The newly developed methodology demonstrated a high overall correlation with the existing CPDB TD50 values.
- Significant discrepancies were identified between the two sets of TD50 values.
- Discrepancies were primarily attributed to the lack of methodological clarity in the CPDB and the inappropriate application of linear models for nonlinear dose-response data.
Conclusions:
- The developed transparent methodology offers a reliable approach for calculating carcinogenic potency (TD50).
- The findings underscore the limitations of the outdated CPDB methodology, particularly concerning its lack of transparency and statistical approach.
- Re-evaluation and consistent application of robust methodologies are crucial for accurate human risk assessment and the establishment of reliable safety guidelines for chemical exposures.
More Related Videos
17:28Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016